Jan 12–15, 2025 | Beaver Run Conference Center, Breckenridge, CO, United States
Scientific Organizers:
John D. Carpten, David Solit, and Chanita H Hughes Halbert

-
Scientific Organizers: John D. Carpten, David Solit, and Chanita H Hughes Halbert
John D. Carpten
David Solit
Chanita H Hughes Halbert
***Meeting program subject to change.
Available Formats: = In Person = On DemandMerchandise Options
Registration Options
Sunday, January 12, 2025
Booking Function
Monday, January 13, 2025
Session Chair
Complex Molecular Characterization of Pediatric Cancers: Setting the Stage for Precision Diagnosis and Therapy
Targeting Ras in Human Cancer
Sensitivity and Resistance to Kinase Inhibitors in Cancer
Targeted Cytotoxics: Advances in Antibody Drug Conjugates
Short Talk: Deciphering the Mechanism Underlying Resistance to pan-RAS Inhibitors
Short Talk: Small Molecule-Based Targeting of PCNA Protein to Develop a Cancer-Selective Chemotherapy
Lessons from the Study of Exceptional Responders
New Clinical Trial Designs for the Precision Medicine Era
Short Talk: Utility of Circulating Tumor DNA (Ctdna) to Support Early Clinical Development of the PKMYT1 Inhibitor Lunresertib (Lunre) Alone or in Combination with the ATR Inhibitor Camonsertib (Cam) in the MYTHIC Phase I Trial
Tuesday, January 14, 2025
Remote Presentation: Precision Oncology Disparities in South Africa
Reimagining Health Equity in the Era of Precision Medicine
Using Precision Oncology to Support Innovation in Prostate Cancer Equity
Intersection Between Social and Biological Risk Factors on the Pathway to Cancer Health Equity
Short Talk: Increased AID Results in Mutations at the CRLF2 Locus Implicated in Latin American ALL Health Disparities
Short Talk: Data-Driven Drug Discovery Targeting Transcription and Replication Collision in Cancer
Session Chair
EP300 Loss of Function is a Pan-Cancer Sensitizer to BET Inhibition
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy
EGFR Alteration Subtype Predicts the Benefit Of Stereotactic Radiosurgery in Patients with NSCLC Brain Metastasis
RAF/MEK Glue Mechanism on RAF Enables RAS Mutant Tumor-Selective Therapy
Professor
Senior Scientist
Professor & Group Leader, Physician Scientist
Session Chair
Advancing Immune Checkpoint Targets in Cancer
Novel Computational Methods to Define Immunotherapy Sensitivity
Integrating Genome Sequencing into Clinical Practice for Cancer Patients
Short Talk: Mapping Spatial Organization and Genetic Cell-State Regulators to Target Immune Evasion in Ovarian Cancer
Short Talk: A Novel Functional Precision Oncology Platform Technology: E-Slice with Intact TME for Immunotherapy and Other Cancer Therapy Response Measurements from Human Tumors
Wednesday, January 15, 2025
Genomic, Immune and Microenvironmental Biomarkers in Breast Cancer
Harnessing Tumor Plasticity for Therapeutic Intent
Short Talk: Linkprep™ – A Comprehensive Assay for Cancer Genome Characterization that Enables Ultra-Sensitive Detection of Structural Variants
Short Talk: Chromatin Profiling from Formalin-Fixed Paraffin-Embedded Samples for Biomarker Discovery
Short Talk: Clinical Implementation of Implantable Microdevices to Identify Highly Effective Treatment Combinations in Cancer Patients
Remote Presentation: Convergence of Machine Learning and Multi-omics for Precision Cancer Medicine
Informatics Strategies for Incorporating Genetic Ancestry in Precision Oncology
Learning what the Immune System Senses in Cancer and When It Matters
Short Talk: Utilizing an Automated, NLP-aided Platform to Generate Large (>10,000 patient), Comprehensive Clinical & Molecular Datasets to Enable a Real-World Evidence Approach to Precision Oncology
Thursday, January 16, 2025
Fundraising
Subscribe for Updates